Less Intense Dosing Schedule for a Bone-Modifying Agent

JAMA Oncol. 2017 Jul 1;3(7):893-894. doi: 10.1001/jamaoncol.2016.6240.
No abstract available

Publication types

  • Comment

MeSH terms

  • Breast Neoplasms*
  • Drug Administration Schedule
  • Female
  • Humans
  • Zoledronic Acid*

Substances

  • Zoledronic Acid